Nimbus Discovery
About Nimbus
Leadership
Board
Advisors
Product Pipeline
IRAK4
ACC
Tyk2
Shire Collaboration
Other Targets
Partnering
Alliances
Shire
Schrödinger
Nimbus Approach
Technologies
Publications
News
Contact
News and Announcements
May 8, 2013
February 6, 2013
January 28, 2013
December 9, 2012
November 12, 2012
November 8, 2012
November 1, 2012
April 20, 2012
April 19, 2012
June 28, 2011
March 10, 2011
News
May 8, 2013
Nimbus and Shire to Co-Develop Therapies for Rare Diseases
February 6, 2013
Wes Westlin Appointed Head of Preclinical Research and Early Development
January 28, 2013
Inhibitors For Treatment of Metabolic Syndrome and Diabetes
December 9, 2012
IRAK4 Inhibitors Synergize with Ibrutinib
November 12, 2012
IRAK4 Inhibitors for the Treatment of Rheumatic Diseases
November 8, 2012
Nimbus-Proteros X-Ray Crystallography Partnership
November 1, 2012
Daniel Lynch Joins Nimbus as Executive Chairman
April 20, 2012
2012 Women to Watch: Rosana Kapeller
April 19, 2012
Cycle Computing Ramps Global 50,000-Core Cluster for Schrodinger Molecular Research
June 28, 2011
Nimbus Discovery Secures $24mm Series A Financing
March 10, 2011
Nimbus Discovery Unveils First Of Its Kind Drug Discovery Paradigm; Announces Seed Round Co-Led By Bill Gates